World's Best Scientists 2026 revealed!
Gianni Tognoni

Gianni Tognoni

Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
129
Citations
84427
World Ranking
2538
National Ranking
59

Gianni Tognoni publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gianni Tognoni sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 753 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gianni Tognoni D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gianni Tognoni sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 129 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Gianni Tognoni is affiliated with the University of Milan in Italy, specializing in health professions with a focus on general health professions. Their research contributions span multiple subfields including genetics, hematology, and nephrology.

The scientist's recent publications address a variety of topics within public health and medical research. These include global health care issues, health disparities and outcomes, employment and welfare studies, and specific disease-related areas such as myeloproliferative neoplasms, platelet disorders, renal diseases, and child and adolescent health.

Examples of recent papers authored or co-authored by Gianni Tognoni include:

  • Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial, 2021, The Lancet Haematology
  • Inequalities in the Universal Right to Health, 2021, International Journal of Environmental Research and Public Health
  • On the duty to protect the people of Gaza: how the collapse of the hospital health care system has reinforced genocidal intent, 2024, Journal of Public Health and Emergency
  • An analysis of death trends in Argentina, 1990-2017, with emphasis on the effects of economic crises, 2020, Journal of Global Health
  • An analysis of death trends in Argentina, 1990-2017, with emphasis on the effects of economic crises., 2020, PubMed

Gianni Tognoni has collaborated frequently with a core group of researchers, including:

  • Alejandro Macchia
  • Javier Mariani
  • Daniel Nul
  • Hugo Grancelli
  • Hernán C. Doval

Their work has been published primarily in venues such as PubMed, The Lancet Haematology, International Journal of Environmental Research and Public Health, Journal of Public Health and Emergency, and Journal of Global Health. PubMed represents the main publication venue with seven contributions.

The thematic scope of Gianni Tognoni's research reflects a broad engagement with public and global health challenges, addressing both clinical and societal dimensions of health care systems and outcomes.

Best Publications

  • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

    S Yusuf;F Zhao;S R Mehta;S Chrolavicius

  • A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure☆

    J.N. Cohn;G. Tognoni

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione

    Roberto Marchioli;Federica Barzi;Elena Bomba;Carmine Chieffo

  • A trial of goal- oriented hemodynamic therapy in critically ill patients

    L Gattinoni;L Brazzi;P Pelosi;R Latini

  • Effect of prone positioning on the survival of patients with acute respiratory failure

    Luciano G. Gattinoni;Gianni Tognoni;Antonio Pesenti;Paolo Taccone

  • Albumin Replacement in Patients with Severe Sepsis or Septic Shock

    Pietro Caironi;Gianni Tognoni;Serge Masson;Roberto Fumagalli

  • Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

    Raffaele Landolfi;Roberto Marchioli;Jack Kutti;Heinz Gisslinger

  • Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

    Inder S. Anand;Lloyd D. Fisher;Yann Tong Chiang;Roberto Latini

  • Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-analysis of Randomized Controlled Trials

    Jeffrey S. Berger;Maria C. Roncaglioni;Fausto Avanzini;Ierta Pangrazzi

  • Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

    Peter M. Rothwell;Jacqueline F. Price;F. Gerald R. Fowkes;Alberto Zanchetti

  • Effect of valsartan on the incidence of diabetes and cardiovascular events.

    John McMurray;R Holman;Steven Haffner;M Bethel

  • Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Raffaele Landolfi;Jack Kutti

  • Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

    Roberto Latini;Roberto Latini;Serge Masson;Inder S. Anand;Emil Missov

  • Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic overview of individual data from 100,000 patients in randomized trials

    M G Franzosi;E Santoro;G Zuanetti;C Baigent

  • Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.

    J Michael Gaziano;J Michael Gaziano;J Michael Gaziano;Carlos Brotons;Rosa Coppolecchia;Claudio Cricelli

  • HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

    Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes

  • The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto

    Paolo Rebulla;Guido Finazzi;Francesca Marangoni;Giuseppe Avvisati

  • A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

    G. Finazzi;R. Marchioli;V. Brancaccio;P. Schinco

Frequent Co-Authors

Aldo P. Maggioni
Aldo P. Maggioni Heart Care Foundation, ANMCO Research Center, Florence
Roberto Latini
Roberto Latini Mario Negri Institute for Pharmacological Research
Luigi Tavazzi
Luigi Tavazzi University of Ferrara
Antonio Nicolucci
Antonio Nicolucci Mario Negri Institute for Pharmacological Research
Jay N. Cohn
Jay N. Cohn University of Minnesota
Fabio Pellegrini
Fabio Pellegrini Biogen (United States)
Luciano Gattinoni
Luciano Gattinoni University of Göttingen
Silvia Franceschi
Silvia Franceschi Centro di Riferimento Oncologico
Antonio Pesenti
Antonio Pesenti University of Milan
Inder S. Anand
Inder S. Anand University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career opportunities related to medicine goes beyond attending traditional medical schools. Today, aspiring healthcare professionals can access numerous flexible online programs that align with their interests and goals. For instance, those seeking entry into healthcare administration can benefit from healthcare administration degrees offered online, which prepare students for management roles in hospitals, clinics, and public health organizations.

If you are interested in nursing, options like lpn school without teas test can offer a less test-heavy admissions process, making the pathway more accessible for many candidates. For current registered nurses aiming to advance their careers, there are rn to np bridge programs that streamline the path from an Associate Degree in Nursing (ADN) to becoming a Nurse Practitioner (NP).

Additionally, those drawn to administrative roles or medical office support can pursue online medical coding classes with financial aid, opening doors in medical billing and record management. These online pathways help diversify your career choices within the evolving healthcare landscape.

Best Scientists Citing Gianni Tognoni

Trending Scientists

Recently Published Articles